Tosoh Bioscience, a leading name in the research and development services sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2002, the company has established itself as a key player in the biopharmaceutical and life sciences industries, focusing on innovative solutions for analytical and preparative chromatography.
With a diverse portfolio that includes high-performance liquid chromatography (HPLC) columns, mass spectrometry products, and bioseparation technologies, Tosoh Bioscience is renowned for its commitment to quality and precision. The company’s unique offerings cater to a wide range of applications, from drug development to environmental analysis, positioning it as a trusted partner in scientific research. Notable achievements include significant advancements in bioprocessing and a strong reputation for customer support, solidifying its market position as a preferred choice for researchers and laboratories worldwide.
+5 vs industry average
Tosoh Bioscience’s score of 34 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Tosoh Bioscience?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Tosoh Bioscience's reported carbon emissions
Tosoh Bioscience is committed to reducing its environmental impact. For fiscal year 2024, the company reported total global emissions of approximately 13.4 billion kg CO2e. This comprised about 7.3 billion kg CO2e in Scope 1 emissions and approximately 468 million kg CO2e in Scope 2 emissions, alongside 5.8 billion kg CO2e in Scope 3 emissions. Looking at previous years, global emissions for fiscal year 2023 were approximately 13.9 billion kg CO2e, with Scope 1 accounting for about 7.6 billion kg CO2e, Scope 2 for around 467 million kg CO2e, and Scope 3 for approximately 5.9 billion kg CO2e. Tosoh Bioscience has set a clear climate target: to reduce Scope 1 and 2 greenhouse gas emissions by 30% in fiscal year 2031, compared to a fiscal year 2019 baseline. This long-term commitment underscores their dedication to climate action within the research and development services sector. The company's emissions data is inherited from its ultimate parent company, Tosoh Corporation, as indicated by the cascaded data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Tosoh Bioscience’s Climate Goals (2030 & 2050)
2 goals2031
30% reduction in Scope 2
Reduce Scope 1 + 2 GHG emissions by 30% in fiscal 2031 compared with fiscal 2019
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
Inherited from Tosoh Corporation
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Tosoh Bioscience
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project